Literature DB >> 11027677

Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.

S Ammanamanchi1, M G Brattain.   

Abstract

MCF-7E breast cancer cells express transforming growth factor-beta (TGF-beta) receptors RI and RII in comparison to MCF-7L cells. We present data showing that Sp3 acts as a transcriptional repressor of RI and RII in MCF-7L cells and GEO colon cancer cells. MCF-7L and GEO cells express high levels of Sp3 protein. Gel shift analysis indicated enhanced binding of Sp3 from MCF-7L cells to a consensus Sp1 oligonucleotide. Southwestern data indicated increased binding of Sp3 to RI and RII promoters in MCF-7L cells, suggesting a correlation between Sp3 binding and reduced expression of TGF-beta receptors in MCF-7L cells. Cotransfection of CMV-Sp3 cDNA with RI and RII promoter-luciferase reporter constructs decreased RI and RII promoter activities by 70% in MCF-7E and GEO cells. Southwestern analysis detected the binding of transiently expressed Sp3 to RI and RII promoters in MCF-7E cells. Significantly, ectopic Sp3 expression led to repression of RI and RII transcripts in MCF-7E cells. This report demonstrates that inappropriate overexpression of Sp3 is a mechanism that contributes to repression of TGF-beta receptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027677     DOI: 10.1074/jbc.M002462200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Functional characterization of the human translocator protein (18kDa) gene promoter in human breast cancer cell lines.

Authors:  Amani Batarseh; Keith D Barlow; Daniel B Martinez-Arguelles; Vassilios Papadopoulos
Journal:  Biochim Biophys Acta       Date:  2011-09-18

2.  Specificity protein 1 regulates fascin expression in esophageal squamous cell carcinoma as the result of the epidermal growth factor/extracellular signal-regulated kinase signaling pathway activation.

Authors:  Xiao-Feng Lu; En-Min Li; Ze-Peng Du; Jian-Jun Xie; Zhang-Yan Guo; Shu-Ying Gao; Lian-Di Liao; Zhong-Ying Shen; Dong Xie; Li-Yan Xu
Journal:  Cell Mol Life Sci       Date:  2010-05-26       Impact factor: 9.261

3.  Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.

Authors:  Sanjib Chowdhury; Gillian M Howell; Carol A Teggart; Aparajita Chowdhury; Jonathan J Person; Dawn M Bowers; Michael G Brattain
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

4.  E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells.

Authors:  Akhilesh Rawat; Gopal Gopisetty; Rajkumar Thangarajan
Journal:  Cell Oncol (Dordr)       Date:  2014-10-22       Impact factor: 6.730

5.  Sp3/REST/HDAC1/HDAC2 Complex Represses and Sp1/HIF-1/p300 Complex Activates ncx1 Gene Transcription, in Brain Ischemia and in Ischemic Brain Preconditioning, by Epigenetic Mechanism.

Authors:  Luigi Formisano; Natascia Guida; Valeria Valsecchi; Maria Cantile; Ornella Cuomo; Antonio Vinciguerra; Giusy Laudati; Giuseppe Pignataro; Rossana Sirabella; Gianfranco Di Renzo; Lucio Annunziato
Journal:  J Neurosci       Date:  2015-05-13       Impact factor: 6.167

6.  Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy.

Authors:  Sanjib Chowdhury; Sudhakar Ammanamanchi; Gillian M Howell
Journal:  Mol Cell Pharmacol       Date:  2009-01-01

7.  Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.

Authors:  Melissa K Hypes; Lucia Pirisi; Kim E Creek
Journal:  Cancer Lett       Date:  2009-04-02       Impact factor: 8.679

8.  Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins.

Authors:  Artit Jinawath; Satoshi Miyake; Yuka Yanagisawa; Yoshimitsu Akiyama; Yasuhito Yuasa
Journal:  Biochem J       Date:  2005-01-15       Impact factor: 3.857

9.  Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells.

Authors:  Neka A K Simms; Ashwani Rajput; Elizabeth A Sharratt; Melanie Ongchin; Carol A Teggart; Jing Wang; Michael G Brattain
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

10.  Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer.

Authors:  Sanjib Chowdhury; Gillian M Howell; Ashwani Rajput; Carol A Teggart; Lisa E Brattain; Hannah R Weber; Aparajita Chowdhury; Michael G Brattain
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.